Daptomycin Injection, Powder, Lyophilized, For Solution
Product Images NDC 16729-434

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Daptomycin (NDC 16729-434). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Accord Healthcare, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Daptomycin For Inj Carton 10x1

Daptomycin for Injection 350 mg/vial powder and lyophilized for solution label. The label instructs to keep refrigerated and reconstitute with 7 mL 0.9% sodium chloride to obtain 50 mg/mL final concentration. Package contains 10 single-dose vials and is labeled for intravenous use only. Manufactured by Accord Healthcare, Inc.*

FDA Label Image

Carton Label (Daptomycin For Inj Carton)

Daptomycin for Injection 350 mg/vial lyophilized powder label by Accord Healthcare, Inc. The label instructs reconstitution with 7 mL of 0.9% sodium chloride injection to obtain a 50 mg/mL solution for intravenous use only. It highlights storage requirements as must be refrigerated between 2° and 8°C and is for single-dose vial use only. The label includes NDC 16729-434 and manufacturing information for Accord Healthcare, Inc. and Intas Pharmaceuticals Limited.*

FDA Label Image

Vial Label (Daptomycin For Inj Label)

Label for Daptomycin for Injection 350 mg per vial, lyophilized powder for solution, for intravenous use. The label states the product must be refrigerated and reconstituted with 7 mL of 0.9% sodium chloride injection. Manufactured for Accord Healthcare, Inc. with manufacturing by Intas Pharmaceuticals Limited, India. Includes NDC 16729-434 and barcode.*

FDA Label Image

Chemical Structure (Daptomycin For Inj Stru)

Chemical structure diagram of daptomycin, showing its cyclic lipopeptide molecular framework with amino acid residues and functional groups represented by standard chemical notation in a two-dimensional layout.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.